Halozyme Therapeutics shares owned by China Universal Asset Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by China Universal Asset Management
from 13F filings
Historical chart of China Universal Asset Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Halozyme Therapeutics by China Universal Asset Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $990k | 24k | 40.66 |
2023-12-31 | $2.0M | 54k | 36.96 |
2023-09-30 | $2.3M | 59k | 38.20 |
2023-06-30 | $1.7M | 48k | 36.07 |
2023-03-31 | $382k | 10k | 38.15 |
2022-12-31 | $1.2M | 22k | 56.90 |
2022-09-30 | $986k | 25k | 39.54 |
More positions owned by China Universal Asset Management
View all positions for China Universal Asset Management